Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A brief introduction to Monte Carlo simulation.

P L Bonate1

  • 1Clinical Pharmacokinetics, Quintiles, Kansas City, Missouri 64134, USA. peter.bonate@quintiles.com

Clinical Pharmacokinetics
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What happened to the modeling and simulation revolution?

Clinical pharmacology and therapeutics·2014
Same author

Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective.

The AAPS journal·2012
Same author

Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response.

British journal of clinical pharmacology·2007
Same author

Prospective allometric scaling: does the emperor have clothes?

Journal of clinical pharmacology·2000
Same author

Rank power of metrics used to assess QTc interval prolongation by clinical trial simulation.

Journal of clinical pharmacology·2000
Same author

Clinical trial simulation in drug development.

Pharmaceutical research·2000
Same journal

Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review.

Clinical pharmacokinetics·2026
Same journal

Partial Area Under the Curve: A Revelatory Story in Pharmacokinetics.

Clinical pharmacokinetics·2026
Same journal

Informing Sampling Design for Lung Distribution Studies Using a Pulmonary Population Minimal PBPK Model.

Clinical pharmacokinetics·2026
Same journal

Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing.

Clinical pharmacokinetics·2026
Same journal

ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

Clinical pharmacokinetics·2026
Same journal

Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer.

Clinical pharmacokinetics·2026
See all related articles

Monte Carlo simulation is an increasingly valuable tool in drug development. This method uses random variables for model parameters, differing from traditional fixed-value simulations.

Area of Science:

  • Computational science
  • Pharmacological research
  • Biostatistics

Background:

  • Simulation is integral to various industries, including automotive, airline, and entertainment.
  • The application of simulation in drug development is a growing field, accelerated by advancements in computing power.
  • Molecular modeling is a recognized simulation technique in drug discovery.

Purpose of the Study:

  • To introduce Monte Carlo simulation methods.
  • To highlight the application of Monte Carlo simulation in clinical trial design.

Main Methods:

  • Monte Carlo simulation is presented as a distinct approach.
  • Key difference: Monte Carlo simulation treats model parameters as stochastic (random) variables.
  • Contrast: Traditional simulation uses fixed values for model parameters.

Related Experiment Videos

Main Results:

  • The paper provides an introduction to Monte Carlo simulation.
  • It positions Monte Carlo simulation as a novel method for clinical trials in drug development.

Conclusions:

  • Monte Carlo simulation offers a probabilistic approach to modeling in drug development.
  • Its adoption in clinical trials is expanding due to its unique methodology.